Receive continuing education (CE) for WC4520-061622 – Calls/webinars for clinician outreach and communication activities (COCA) – What clinicians need to know about the treatment options available for COVID-19, Thursday, June 16, 2022, please visit TCEO and follow these 9 simple steps by Monday, July 18, 2022.
Receive continuing education (CE) for WD4520-061622 – Calls/webinars for clinician outreach and communication activities (COCA) – What clinicians need to know about the treatment options available for COVID-19, Thursday, June 16, 2022, (web on demand), please visit TCEO and follow these 9 simple steps Between Tuesday July 19, 2022, and Friday July 19, 2024.
To support improved patient care, the Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to ensure ongoing training for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this activity for a maximum of 1 AMA PRA Category 1™ credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AAPA CME: The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME criteria. This activity is intended for 1 AAPA Category 1 CME credits. The authorization is valid until 12/13/2023. PAs should only claim credit commensurate with the extent of their participation
CNE: The Centers for Disease Control and Prevention designates this activity to 1 nursing contact hours.
CPE: The Centers for Disease Control and Prevention have designated this (Based on knowledge) event for pharmacists to receive 0.1 CEU in pharmacy education. The universal activity number is JA4008229-0000-22-057-L04-P and enduring JA4008229-0000-22-058-H04-P.
Once credit is claimed, an unofficial credit statement is immediately available on TCEOnline. The official credit will be uploaded within 60 days to the NABP/CPE Monitor.
CFU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU for this program.
ECHC: Sponsored by the Centers for Disease Control and Prevention, a Designated Provider of Continuing Education Hours (CECH) in Health Education by the National Commission for Health Education Credentialing, Inc. This program is for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCCHES®) to receive up to 1.0 Total Category I continuing education hours. The maximum number of advanced level continuing education contact hours available is 1. The maintenance of competence credits available are 1. CDC supplier number 98614.
AAVSB/RACE: This program has been reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limits on the number of hours accepted in certain categories and/or restrictions on certain methods of delivering continuing education. Please contact the AAVSB RACE program at [email protected] if you have any comments/concerns regarding the validity or suitability of this program for the veterinary profession.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.
DISCLOSURE: In accordance with continuing education requirements, all planners and presenters must disclose all financial relationships, regardless of amount, with ineligible companies in the previous 24 months as well as any use of unlabeled product(s) or products for experimental use.
CDC, our planners and our presenters wish to disclose that they have no financial relationship with non-eligible companies whose principal activity is the production, marketing, sale, resale or distribution of health products used by or on patients, with the exception of Dr. Eric Daar who would like to reveal that he provides research support and is an HIV consultant for Gilead, Merck and GSK/ViiV.
All relevant financial relationships listed for this person have been mitigated.
Content will not include any discussion of unlabeled use of a product or product under investigational use.
CDC has not accepted financial or in-kind support from ineligible companies for this continuing education activity.